INDOCO REMEDIES
Back to Cashflow Statement
|
INDOCO REMEDIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹192 Cr | ₹95 Cr | ₹155 Cr | ₹179 Cr | ₹174 Cr |
What is the latest Cash Flow from Operating Activities ratio of INDOCO REMEDIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹192 Cr |
| Mar2025 | ₹95 Cr |
| Mar2024 | ₹155 Cr |
| Mar2023 | ₹179 Cr |
| Mar2022 | ₹174 Cr |
How is Cash Flow from Operating Activities of INDOCO REMEDIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹192 Cr | 102.48 | |
| Mar2025 | ₹95 Cr | -38.90 | |
| Mar2024 | ₹155 Cr | -13.11 | |
| Mar2023 | ₹179 Cr | 2.88 | |
| Mar2022 | ₹174 Cr | - | |
Compare Cash Flow from Operating Activities of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,078.6 Cr | 3.2% | -9.1% | -24.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,952.0 Cr | 1% | -2.9% | 17.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹230,427.0 Cr | 1.8% | 17% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,141.0 Cr | -1.9% | -1.9% | 33.2% | Stock Analytics | |
| CIPLA | ₹114,715.0 Cr | 0.3% | 0.7% | -7.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,409.9 Cr | 1.7% | 3.5% | -4.1% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | 3.2% |
-9.1% |
-24.9% |
| SENSEX | 0.5% |
2.1% |
-4.5% |
You may also like the below Video Courses